{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:09:15Z","timestamp":1648634955658},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1977,8,1]],"date-time":"1977-08-01T00:00:00Z","timestamp":239241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experientia"],"published-print":{"date-parts":[[1977,8]]},"DOI":"10.1007\/bf01945939","type":"journal-article","created":{"date-parts":[[2005,7,27]],"date-time":"2005-07-27T17:10:27Z","timestamp":1122484227000},"page":"1012-1014","source":"Crossref","is-referenced-by-count":3,"title":["Isotope effect studies on the dehydrogenation of \u03941-tetrahydrocannabinol in the rat"],"prefix":"10.1007","volume":"33","author":[{"given":"N. K.","family":"McCallum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gugelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A. M.","family":"Brenninkmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01945939_CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.169.3945.611","volume":"169","author":"R. Mechoulam","year":"1970","unstructured":"R. Mechoulam, A. Shani, H. Edery and Y. Grunfeld, Science169, 611 (1970).","journal-title":"Science"},{"key":"BF01945939_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00429130","volume":"38","author":"M. Fermandes","year":"1974","unstructured":"M. Fermandes, A. Schabarek, H. Coper and R. Hill, Psychopharmacologia38, 329 (1974); R. N. Takahashi and I. G. Karniol, Psychopharmacologia41, 277 (1975); and cited references.","journal-title":"Psychopharmacologia"},{"key":"BF01945939_CR3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/BF02358875","volume":"31","author":"N. K. McCallum","year":"1975","unstructured":"N. K. McCallum, Experientia31, 957 (1975).","journal-title":"Experientia"},{"key":"BF01945939_CR4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF01932433","volume":"31","author":"N. K. McCallum","year":"1975","unstructured":"N. K. McCallum, B. Yagen, S. Levy and R. Mechoulam, Experientia31, 520 (1975).","journal-title":"Experientia"},{"key":"BF01945939_CR5","unstructured":"S. Aronoff, in: Techniques and Radiobiochemistry, p. 9. Iowa State College Press, 1956."},{"key":"BF01945939_CR6","unstructured":"3H-\u03941-THC labelled at C(3), was the kind gift of Dr S. Burstein of the Worcester Foundation for Experimental Biology;14C-\u03941-THC labellet at C(6\u2032) and C(4\u2032) in the aromatic ring was kindly supplied by Dr M. Braude of the National Institute on Drug Abuse, Maryland, USA."},{"key":"BF01945939_CR7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0021-9673(01)81064-5","volume":"106","author":"J. A. Vinson","year":"1975","unstructured":"J. A. Vinson and J. E. Hooyman, J. Chromatogr.106, 196 (1975).","journal-title":"J. Chromatogr."},{"key":"BF01945939_CR8","unstructured":"Purities of the cannabinoids were: \u03941-THC contained 0.4% CBN by standard glc techniques and 0.1% CBN using varied exposures of a thin layer chromatogram to photographic plates; the CBN was 99.5% pure with ca. 0.1% \u03941-THC by glc."},{"key":"BF01945939_CR9","unstructured":"Male Sprague-Dawley rats (130\u2013150 g) were used with 1 mg CBN and\/or 1 mg3H,14C-\u03941-THC (ca. 4 \u03bcCi in total) per administration."},{"key":"BF01945939_CR10","unstructured":"The propylene glycol showed a tendency to absorb moisture from the air causing the solution to form a cloudy, microsuspension of cannabinoid. Results using such a solution tended to be erratic (generally higher) unless the cannabinoid was solubilized by further warming or addition of traces of acetone and remixed."},{"key":"BF01945939_CR11","volume-title":"Applications of Liquid Scintillation Counting","author":"Donald L. Horrocks","year":"1974","unstructured":"Donald L. Horrocks, Applications of Liquid Scintillation Counting. Academic Press, New York and London 1974."},{"key":"BF01945939_CR12","unstructured":"On the basis of blood level data6 it can be argued that up to 35 sec after administration the injection plug is moving from the tail to the heart, and thus mixing (and therefore metabolism) can only take place after it reaches the heart, i.e. between 35 and 40 sec after administration. If this is the case the latter period represents not 42, but over 300 times the initial period during which metabolism is taking place."},{"key":"BF01945939_CR13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jps.2600630705","volume":"63","author":"E. R. Garrett","year":"1974","unstructured":"E. R. Garrett and C. A. Hunt, J. pharm. Sci.63, 1056 (1974).","journal-title":"J. pharm. Sci."},{"key":"BF01945939_CR14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3181\/00379727-147-38444","volume":"147","author":"W. H. Oldendort","year":"1974","unstructured":"W. H. Oldendort, Proc. Soc. exp. Biol. Med.147, 813 (1974).","journal-title":"Proc. Soc. exp. Biol. Med."},{"key":"BF01945939_CR15","unstructured":"A. Goldstein, L. Aronow and S. M. Calman, Principles of Drug Action: The basis of Pharmacology, 2nd ed., p. 190. John Wiley & Sons Inc., 1974."},{"key":"BF01945939_CR16","first-page":"63","volume-title":"Pharmacology of Marihuana","year":"1975","unstructured":"Pharmacology of Marihuana, p. 63. Ed. M. C. Braude and S. Szara. Raven Press, New York 1975."},{"key":"BF01945939_CR17","first-page":"1","volume":"128","author":"Thiopental A. Goldstein","year":"1960","unstructured":"Thiopental A. Goldstein and L. Aronow, J. Pharmac. exp. Ther.128, 1 (1960) provies ans analogy with \u03941-THC. In this case lower lipophilicity results in less protein binding and would be expected to result in much less retention of the drug by the brain.","journal-title":"J. Pharmac. exp. Ther."},{"key":"BF01945939_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.173.3991.72","volume":"173","author":"L. Lemberger","year":"1971","unstructured":"L. Lemberger, N. R. Tamarkin, J. Axelod and I. J. Kopin, Science173, 72 (1971).","journal-title":"Science"}],"container-title":["Experientia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01945939.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01945939\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01945939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T16:49:39Z","timestamp":1557766179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01945939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1977,8]]}},"alternative-id":["BF01945939"],"URL":"https:\/\/doi.org\/10.1007\/bf01945939","relation":{},"ISSN":["0014-4754","1420-9071"],"issn-type":[{"value":"0014-4754","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,8]]}}}